Clinical Trial Update: Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 trial investigating letrozole with or without BYL719 or buparlisib as neoadjuvant therapy for postmenopausal women with breast cancer; study completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• BYL719 (alpelisib)
• Buparlisib (buparlisib)
• Letrozole (letrozole)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-09-14